CDKN3 in cancer: one phosphatase, many contradictory stories
A new narrative review argues that conflicting CDKN3 findings across cancers reflect incompatible evidence types, not a true molecular paradox.
A new narrative review argues that conflicting CDKN3 findings across cancers reflect incompatible evidence types, not a true molecular paradox.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.